Vimarsana
Biggest News Aggregation in the World

Philip Serlin News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Philip Serlin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Philip Serlin Today - Breaking & Trending Today

BioLineRx : Reports First Quarter 2024 Financial Results and Recent Corporate and Portfolio Updates - Vimarsana News

BioLineRx : Reports First Quarter 2024 Financial Results and Recent Corporate and Portfolio Updates

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER ...

BioLineRx to Report First Quarter 2024 Results on May 28, 2024 - Vimarsana News

BioLineRx to Report First Quarter 2024 Results on May 28, 2024

Management to Hold Conference Call at 8:30 a.m. EDT TEL AVIV, Israel, May 22, 2024 /PRNewswire/ -- BioLineRx Ltd. , a commercial stage biopharmaceutical company pursuing life-changing therapies in...

BioLineRx Accesses Second Tranche of $20 Million Under Previously Announced $40 Million Non-Dilutive Debt Financing Agreement - Vimarsana News

BioLineRx Accesses Second Tranche of $20 Million Under Previously Announced $40 Million Non-Dilutive Debt Financing Agreement

/PRNewswire/ -- BioLineRx Ltd. (NASDAQ/TASE: BLRX), a commercial stage biopharmaceutical company pursuing life-changing therapies in oncology and rare...

BioLineRx : Report of Periodic or Interim Report -March 26, 2024 at 08:26 am EDT - Vimarsana News

BioLineRx : Report of Periodic or Interim Report -March 26, 2024 at 08:26 am EDT

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE...

BioLineRx : Reports 2023 Financial Results and Recent Corporate and Portfolio Updates -March 26, 2024 at 07:36 am EDT - Vimarsana News

BioLineRx : Reports 2023 Financial Results and Recent Corporate and Portfolio Updates -March 26, 2024 at 07:36 am EDT

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE...